InvestorsHub Logo
icon url

dabullishbear

03/08/18 4:26 PM

#16909 RE: laraz5 #16908

No one has been "ripped off". Retail traders are 99.9% the reason for the price action. Oncolix has been answering questions and has been keeping shareholders up to date on all of its current business practices and milestones.

When do we question "Ripoff" Redman and the practices that have tumble the PPS to .20 to .03? When does someone in this company start to answer questions about real business an stops toying with the typical manipulated notion about Market Makers and moving pricing?



Oncolix has disclosed that it has dosed 3 patients and it's even put in to the language of several filings. Did you miss that?

2 year and 1 month of clinical trials have produced Nothing? Oncolix can't reveal if it dosed any patients in the current Phase 1 trials because that would be unethical?



It would be unethical to disclosed the names of the people involved in the trial. But like I said above, Oncolix has disclosed publicly and in the filings that they have treated and dosed 3 patients. What more do you want?

However they disclosed 3 patients prior to the current Trial? Thats ethical? I'll recall we have no verifiable happenings of any of those 3 mythical patients and what has happened since?




icon url

dabullishbear

03/08/18 4:32 PM

#16910 RE: laraz5 #16908

***AMAZING INVESTMENT OPPORTUNITY***

At this point, getting Prolanta though phase I is just a formality. Prolanta is 99% the same drug as Somavert. If you want to get an idea of how we will perform in phase I, go look at the Somavert trials. The only question that matters and it is what we will find out from completing 2-3 trial phases is: Does antagonizing human prolactin receptors result in an effective cancer treatment as either a monotherapy or combination therapy with chemo?

Based on the data and research, it's pretty much a given that Prolanta will be an effective antagonist, and Dr Wen Chen has already demonstrated that G129R is a pure hPRL receptor antagonist. Does a pure prolactin receptor antagonist actually treat cancer? I don't think it's a coincidence that doctors and scientists have been trying to find an effective way to antagonize human prolactin for the past 20-30 years. They know it plays a major role in many cancers. G129R is the only pure antagonist being developed at the moment. Knowing how effective Somavert is at antagonizing hGH and how similar and related hGH is to hPRL, and that Prolanta is essentially the same drug as Somavert, the odds are pretty good here.

IMO
icon url

BLight1911

03/10/18 7:44 PM

#16967 RE: laraz5 #16908

When do we question “Redman the Miracle Man with the Master Man”? Seriously, when do we question him?

If the alleged gold mine and alleged triangle mine? Alleged fountain of you triangle scheme mine? How many question mark mines do we have to question mark???

Question?

oncx?

IMO?